<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK121988" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK121988/" /><meta name="ncbi_pagename" content="Neurodegeneration with Brain Iron Accumulation Disorders Overview - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Neurodegeneration with Brain Iron Accumulation Disorders Overview - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Neurodegeneration with Brain Iron Accumulation Disorders Overview" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/10/21" /><meta name="citation_author" content="Allison Gregory" /><meta name="citation_author" content="Susan Hayflick" /><meta name="citation_pmid" content="23447832" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK121988/" /><meta name="citation_keywords" content="NBIA" /><meta name="citation_keywords" content="Aceruloplasminemia" /><meta name="citation_keywords" content="Neuroferritinopathy" /><meta name="citation_keywords" content="Pantothenate Kinase-Associated Neurodegeneration" /><meta name="citation_keywords" content="Fatty Acid Hydroxylase-Associated Neurodegeneration" /><meta name="citation_keywords" content="PLA2G6-Associated Neurodegeneration" /><meta name="citation_keywords" content="Mitochondrial Membrane Protein-Associated Neurodegeneration" /><meta name="citation_keywords" content="Woodhouse-Sakati Syndrome" /><meta name="citation_keywords" content="Kufor-Rakeb Syndrome" /><meta name="citation_keywords" content="Beta-Propeller Protein-Associated Neurodegeneration" /><meta name="citation_keywords" content="COASY protein-associated neurodegeneration" /><meta name="citation_keywords" content="85/88 kDa calcium-independent phospholipase A2" /><meta name="citation_keywords" content="Bifunctional coenzyme A synthase" /><meta name="citation_keywords" content="Cation-transporting ATPase 13A2" /><meta name="citation_keywords" content="Ceruloplasmin" /><meta name="citation_keywords" content="DDB1- and CUL4-associated factor 17" /><meta name="citation_keywords" content="Fatty acid 2-hydroxylase" /><meta name="citation_keywords" content="Ferritin light chain" /><meta name="citation_keywords" content="Pantothenate kinase 2, mitochondrial" /><meta name="citation_keywords" content="Protein C19orf12" /><meta name="citation_keywords" content="WD repeat domain phosphoinositide-interacting protein 4" /><meta name="citation_keywords" content="ATP13A2" /><meta name="citation_keywords" content="C19orf12" /><meta name="citation_keywords" content="COASY" /><meta name="citation_keywords" content="CP" /><meta name="citation_keywords" content="DCAF17" /><meta name="citation_keywords" content="FA2H" /><meta name="citation_keywords" content="FTL" /><meta name="citation_keywords" content="PANK2" /><meta name="citation_keywords" content="PLA2G6" /><meta name="citation_keywords" content="WDR45" /><meta name="citation_keywords" content="Neurodegeneration with Brain Iron Accumulation Disorders" /><meta name="citation_keywords" content="Overview" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Neurodegeneration with Brain Iron Accumulation Disorders Overview" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Allison Gregory" /><meta name="DC.Contributor" content="Susan Hayflick" /><meta name="DC.Date" content="2019/10/21" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK121988/" /><meta name="description" content="The purpose of this overview is to increase the awareness of clinicians regarding neurodegeneration with brain iron accumulation (NBIA) disorders and their genetic causes and management." /><meta name="og:title" content="Neurodegeneration with Brain Iron Accumulation Disorders Overview" /><meta name="og:type" content="book" /><meta name="og:description" content="The purpose of this overview is to increase the awareness of clinicians regarding neurodegeneration with brain iron accumulation (NBIA) disorders and their genetic causes and management." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK121988/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/nbia-ov/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK121988/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8AC2A1E040BF310000000002DA0104.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK121988_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK121988_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/nephron-ov/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/neuroferritin/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK121988_"><span class="title" itemprop="name">Neurodegeneration with Brain Iron Accumulation Disorders Overview</span></h1><p class="contrib-group"><span itemprop="author">Allison Gregory</span>, MS, CGC and <span itemprop="author">Susan Hayflick</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK121988_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK121988_ai__"><div class="contrib half_rhythm"><span itemprop="author">Allison Gregory</span>, MS, CGC<div class="affiliation small">Oregon Health &#x00026; Science University<br />Portland, Oregon<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.usho@ayrogerg" class="oemail">ude.usho@ayrogerg</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Susan Hayflick</span>, MD<div class="affiliation small">Oregon Health &#x00026; Science University<br />Portland, Oregon<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.usho@kcilfyah" class="oemail">ude.usho@kcilfyah</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">February 28, 2013</span>; Last Update: <span itemprop="dateModified">October 21, 2019</span>.</p><p><em>Estimated reading time: 16 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="nbia-ov.Summary" itemprop="description"><h2 id="_nbia-ov_Summary_">Summary</h2><p>The purpose of this overview is to increase the awareness of clinicians regarding neurodegeneration with brain iron accumulation (NBIA) disorders and their genetic causes and management.</p><p>The following are the goals of this overview.</p><div><h4 class="inline">Goal 1.</h4><p>Describe the <a href="#nbia-ov._escape__1_Clinical_Characterist">clinical characteristics</a> of neurodegeneration with brain iron accumulation.</p></div><div><h4 class="inline">Goal 2.</h4><p>Review the <a href="#nbia-ov._escape__2_Genetic_Causes_of_Neu">genetic causes</a> of neurodegeneration with brain iron accumulation.</p></div><div><h4 class="inline">Goal 3.</h4><p>Provide an <a href="#nbia-ov._escape__3_Evaluation_Strategies">evaluation strategy</a> to identify the genetic cause of neurodegeneration with brain iron accumulation in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> (when possible).</p></div><div><h4 class="inline">Goal 4.</h4><p>Inform <a href="#nbia-ov._escape__4_Genetic_Counseling_of">genetic counseling</a> of family members of an individual with neurodegeneration with brain iron accumulation.</p></div><div><h4 class="inline">Goal 5.</h4><p>Review high-level <a href="#nbia-ov._escape__5_Management_of_Neurode">management</a> of neurodegeneration with brain iron accumulation.</p></div></div><div id="nbia-ov._escape__1_Clinical_Characterist"><h2 id="_nbia-ov__escape__1_Clinical_Characterist_">1. Clinical Characteristics of Neurodegeneration with Brain Iron Accumulation</h2><p>Neurodegeneration with brain iron accumulation (NBIA) is a group of inherited neurologic disorders characterized by abnormal accumulation of iron in the basal ganglia (most often in the globus pallidus and/or substantia nigra) (see <a class="figpopup" href="/books/NBK121988/table/nbia-ov.T.neurodegeneration_with_brain_i/?report=objectonly" target="object" rid-figpopup="fignbiaovTneurodegenerationwithbraini" rid-ob="figobnbiaovTneurodegenerationwithbraini">Table 2</a>).</p><p>Generalized cerebral atrophy and cerebellar atrophy are frequently observed.</p><p>The hallmark clinical manifestations of NBIA are progressive dystonia and dysarthria, spasticity, parkinsonism, neuropsychiatric abnormalities, and optic atrophy or retinal degeneration. Although cognitive decline occurs in some genetic types, more often cognition is relatively spared.</p><p>Onset ranges from infancy to adulthood. Progression can be rapid or slow with long periods of stability.</p><div id="nbia-ov.Diagnosis_of_NBIA"><h3>Diagnosis of NBIA</h3><p>The quality of the neuroimaging, including magnet strength and spacing of image slices, can limit the ability to accurately identify abnormal brain iron. Iron-sensitive sequences, such as SWI, GRE, and T<sub>2</sub>*, should be used as a first-line diagnostic investigation to identify the characteristic changes in NBIA. By the time clear neurologic features are present, the brain MRI almost always shows characteristic changes, although iron may be visible only later in the disease course.</p><p>Neuropathologic findings include axonal spheroids in the CNS and, in some types, in peripheral nerves.</p></div><div id="nbia-ov.Differential_Diagnosis_of_NBIA"><h3>Differential Diagnosis of NBIA</h3><p>The differential diagnosis of NBIA is usually based on a brain MRI that raises the suspicion of abnormal iron accumulation (<a class="figpopup" href="/books/NBK121988/table/nbia-ov.T._escape_conditions_with_brain/?report=objectonly" target="object" rid-figpopup="fignbiaovTescapeconditionswithbrain" rid-ob="figobnbiaovTescapeconditionswithbrain">Table 1</a>).</p><div id="nbia-ov.T._escape_conditions_with_brain" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Conditions with Brain MRI Findings or Clinical Findings that Resemble NBIA</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK121988/table/nbia-ov.T._escape_conditions_with_brain/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__nbia-ov.T._escape_conditions_with_brain_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Findings</th><th id="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Condition(s)</th><th id="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Gene(s)&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">T<sub>2</sub>-weighted hyperintensity in globus pallidus reminiscent of early PKAN</td><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Fucosidosis</td><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><i>FUC1A</i></td></tr><tr><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:top;"><a href="/books/n/gene/glutaric-a1/">Glutaric aciduria I</a></td><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><i>GCDH</i></td></tr><tr><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Leigh encephalopathy / pyruvate dehydrogenase deficiency</td><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Several nuclear &#x00026; mitochondrial</td></tr><tr><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Cerebellar &#x00026; cerebral atrophy, thin corpus callosum</div></li><li class="half_rhythm"><div>Optic atrophy</div></li></ul></td><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div><a href="/books/n/gene/hsp/">Spastic paraplegia 30</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/hsan2/">Hereditary sensory neuropathy IIC</a></div></li></ul></td><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KIF1A</i></td></tr><tr><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>T<sub>2</sub>-weighted hypointensity in globus pallidus</div></li><li class="half_rhythm"><div>Childhood-onset dystonia</div></li><li class="half_rhythm"><div>Prominent cervical, cranial, &#x00026; laryngeal dystonia</div></li></ul></td><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/kmt2b-dystonia/"><i>KMT2B</i>-related dystonia</a> (DYT28, DYT-KMT2B)</td><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KMT2B</i></td></tr><tr><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Case report of iron accumulation in basal ganglia</div></li><li class="half_rhythm"><div>Early-onset dystonia-parkinsonism</div></li></ul></td><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early-onset dystonia-parkinsonism</td><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PSEN1</i></td></tr><tr><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Susceptibility-weighted signal dropout in globus pallidus &#x00026; substantia nigra</div></li><li class="half_rhythm"><div>Adult-onset gait change &#x00026; &#x02191; tone</div></li></ul></td><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/leukodys-ov/">SCPx deficiency</a></td><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SCP2</i></td></tr><tr><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>T<sub>2</sub>-weighted hypointensity of globus pallidus &#x00026; striatum that is hyperintense on T<sub>1</sub>-weighted imaging</div></li><li class="half_rhythm"><div>Childhood-onset dystonia &#x00026; spasticity</div></li></ul></td><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/slc39a14-def/">SLC39A14 deficiency</a> (<i>SLC39A14</i>-related early-onset dystonia-parkinsonism)</td><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC39A14</i></td></tr><tr><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>T<sub>2</sub>-weighted hypointensity of globus pallidus, mild cerebellar atrophy, childhood onset</div></li><li class="half_rhythm"><div>Childhood onset of ataxia, dystonia, &#x00026; gaze palsy</div></li></ul></td><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/ataxias/">Neurodegeneration w/ataxia, dystonia, &#x00026; gaze palsy, childhood onset</a> (NADGP)</td><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SQSTM1</i></td></tr><tr><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Cerebellar atrophy, thinning of corpus callosum, dysarthria, gait change</td><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>UBTF</i>-related neuroregression</td><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>UBTF</i></td></tr><tr><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Acanthocytes, oral dystonia</td><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/chac/">Chorea-acanthocytosis</a></td><td headers="hd_h_nbia-ov.T._escape_conditions_with_brain_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><i>VPS13A</i></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="nbia-ov.TF.1.1"><p class="no_margin">Genes are listed alphabetically.</p></div></dd></dl></div></div></div></div></div><div id="nbia-ov._escape__2_Genetic_Causes_of_Neu"><h2 id="_nbia-ov__escape__2_Genetic_Causes_of_Neu_">2. Genetic Causes of Neurodegeneration with Brain Iron Accumulation</h2><p>The ten genes known to be associated with types of NBIA are <i>ATP13A2</i>, <i>C19orf12</i>, <i>COASY</i>, <i>CP</i>, <i>DCAF17</i>, <i>FA2H</i>, <i>FTL</i>, <i>PANK2</i>, <i>PLA2G6</i>, and <i>WDR45</i> (<a class="figpopup" href="/books/NBK121988/table/nbia-ov.T.neurodegeneration_with_brain_i/?report=objectonly" target="object" rid-figpopup="fignbiaovTneurodegenerationwithbraini" rid-ob="figobnbiaovTneurodegenerationwithbraini">Table 2</a>).</p><div id="nbia-ov.T.neurodegeneration_with_brain_i" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Neurodegeneration with Brain Iron Accumulation: Genetic Types</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK121988/table/nbia-ov.T.neurodegeneration_with_brain_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__nbia-ov.T.neurodegeneration_with_brain_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NBIA Genetic Type</th><th id="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">% of all NBIA</th></tr></thead><tbody><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATP13A2</i></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Kufor-Rakeb syndrome (OMIM <a href="https://omim.org/entry/606693" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">606693</a>)</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>C19orf12</i></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mt-mpan/">Mitochondrial membrane protein-associated neurodegeneration</a> (MPAN)</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR, AD&#x000a0;<sup>3</sup></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5%-10%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COASY</i></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">COASY protein-associated neurodegeneration&#x000a0;<sup>5</sup> (CoPAN; OMIM <a href="https://omim.org/entry/618266" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">618266</a>)</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare</td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CP</i></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/acp/">Aceruloplasminemia</a></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare</td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DCAF17</i></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/wss/">Woodhouse-Sakati syndrome</a></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FA2H</i></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/fahn/">Fatty acid hydroxylase-associated neurodegeneration</a> (FAHN)</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FTL</i></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/neuroferritin/">Neuroferritinopathy</a></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare</td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PANK2</i></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pkan/">Pantothenate kinase-associated neurodegeneration</a> (PKAN)</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">30%-35%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PLA2G6</i></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/inad/"><i>PLA2G6</i>-associated neurodegeneration</a> (PLAN)</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10%-15%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>WDR45</i></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/bpan/">Beta-propeller protein-associated neurodegeneration</a> (BPAN)</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">40%-45%&#x000a0;<sup>4</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="nbia-ov.TF.2.1"><p class="no_margin">Genes are listed alphabetically.</p></div></dd><dt>2. </dt><dd><div id="nbia-ov.TF.2.2"><p class="no_margin">Pathogenic variants in <i>ATP13A2</i> were identified in the family originally reported with Kufor-Rakeb syndrome and a handful of other cases worldwide [<a class="bk_pop" href="#nbia-ov.REF.behrens.2010.1929">Behrens et al 2010</a>, <a class="bk_pop" href="#nbia-ov.REF.br_ggemann.2010.1357">Br&#x000fc;ggemann et al 2010</a>, <a class="bk_pop" href="#nbia-ov.REF.schneider.2010.979">Schneider et al 2010</a>, <a class="bk_pop" href="#nbia-ov.REF.chien.2011.1364">Chien et al 2011</a>, <a class="bk_pop" href="#nbia-ov.REF.eiberg.2012.256">Eiberg et al 2012</a>].</p></div></dd><dt>3. </dt><dd><div id="nbia-ov.TF.2.3"><p class="no_margin">Autosomal dominant inheritance and <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> dominant pathogenic sequence variants have been reported in some families [<a class="bk_pop" href="#nbia-ov.REF.gregory.2019.e00736">Gregory et al 2019</a>].</p></div></dd><dt>4. </dt><dd><div id="nbia-ov.TF.2.4"><p class="no_margin">Based on prevalence in the International Registry for NBIA and Related Disorders from the Hayflick laboratory</p></div></dd><dt>5. </dt><dd><div id="nbia-ov.TF.2.5"><p class="no_margin"><a class="bk_pop" href="#nbia-ov.REF.dusi.2014.11">Dusi et al [2014]</a>, <a class="bk_pop" href="#nbia-ov.REF.evers.2017.1878">Evers et al [2017]</a></p></div></dd><dt>6. </dt><dd><div id="nbia-ov.TF.2.6"><p class="no_margin">Described in several Saudi Arabian families [<a class="bk_pop" href="#nbia-ov.REF.woodhouse.1983.216">Woodhouse &#x00026; Sakati 1983</a>, <a class="bk_pop" href="#nbia-ov.REF.alsemari.2007.149">Al-Semari &#x00026; Bohlega 2007</a>]</p></div></dd><dt>7. </dt><dd><div id="nbia-ov.TF.2.7"><p class="no_margin">Documented in seven unrelated families to date [<a class="bk_pop" href="#nbia-ov.REF.dick.2008.248">Dick et al 2008</a>, <a class="bk_pop" href="#nbia-ov.REF.edvardson.2008.643">Edvardson et al 2008</a>, <a class="bk_pop" href="#nbia-ov.REF.dick.2010.e1251">Dick et al 2010</a>, <a class="bk_pop" href="#nbia-ov.REF.kruer.2010.611">Kruer et al 2010</a>]</p></div></dd></dl></div></div></div><p>The distinctive clinical and neuroimaging findings of the ten genetically defined NBIA types are summarized in <a class="figpopup" href="/books/NBK121988/table/nbia-ov.T.neurodegeneration_with_brain_i_1/?report=objectonly" target="object" rid-figpopup="fignbiaovTneurodegenerationwithbraini1" rid-ob="figobnbiaovTneurodegenerationwithbraini1">Tables 3</a> and <a class="figpopup" href="/books/NBK121988/table/nbia-ov.T.neurodegeneration_with_brain_i_2/?report=objectonly" target="object" rid-figpopup="fignbiaovTneurodegenerationwithbraini2" rid-ob="figobnbiaovTneurodegenerationwithbraini2">4</a>, respectively.</p><div id="nbia-ov.T.neurodegeneration_with_brain_i_1" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Neurodegeneration with Brain Iron Accumulation: Clinical Characteristics by Genetic Type</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK121988/table/nbia-ov.T.neurodegeneration_with_brain_i_1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__nbia-ov.T.neurodegeneration_with_brain_i_1_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_1" colspan="2" scope="colgroup" rowspan="1" style="background-color:rgb(242,242,242);text-align:left;vertical-align:middle;">NBIA Genetic Type</th><th id="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_2" scope="col" rowspan="1" colspan="1" style="background-color:rgb(242,242,242);text-align:left;vertical-align:middle;">Onset</th><th id="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_3" scope="col" rowspan="1" colspan="1" style="background-color:rgb(242,242,242);text-align:left;vertical-align:middle;">Typical Presentation</th><th id="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_4" scope="col" rowspan="1" colspan="1" style="background-color:rgb(242,242,242);text-align:left;vertical-align:middle;">Other Key Clinical Manifestations</th></tr></thead><tbody><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pkan/">PKAN</a></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Classic<br />PKAN</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early (w/rapid progression)</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gait abnormalities at age ~3 yrs</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_4" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Progressive dystonia, dysarthria, rigidity, spasticity, hyperreflexia, &#x00026; extensor toe signs</div></li><li class="half_rhythm"><div>Retinal degeneration is common &#x00026; may be detected by ERG several yrs before onset of visual symptoms.</div></li><li class="half_rhythm"><div>Neuropsychiatric symptoms (more frequent in later-onset form)</div></li></ul></td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Atypical<br />PKAN</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;10 yrs (w/slower progression)</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dysarthria</td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/inad/">PLAN</a><br />(Parkinson disease 14; PARK14)</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Infantile<br />PLAN<br />(INAD)</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6 mos - 3 yrs</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental regression, initial hypotonia, progressive psychomotor delay, &#x00026; progressive spastic tetraparesis</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Progressive cognitive decline</div></li><li class="half_rhythm"><div>Strabismus, nystagmus, &#x00026; optic atrophy</div></li><li class="half_rhythm"><div>Rapid disease progression</div></li></ul></td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Juvenile<br />PLAN&#x000a0;<sup>1</sup></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Typically early childhood</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gait instability, ataxia, or speech delay &#x00026; autistic features</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neuropsychiatric disturbances</div></li><li class="half_rhythm"><div>Dystonia &#x00026; spastic tetraparesis</div></li><li class="half_rhythm"><div>Cognitive decline</div></li><li class="half_rhythm"><div>Slower progression</div></li></ul></td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Adult<br />PLAN</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early adulthood</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gait disturbance or neuropsychiatric changes</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Marked cognitive decline</div></li><li class="half_rhythm"><div>Subacute onset of dystonia-parkinsonism</div></li><li class="half_rhythm"><div>Eye movement abnormalities</div></li><li class="half_rhythm"><div>Pyramidal tract signs</div></li></ul></td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mt-mpan/">MPAN</a>&#x000a0;<sup>2</sup></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Childhood to early adulthood</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Children: gait abnormalities, limb spasticity, optic atrophy<br />Adults: gait abnormalities, acute neuropsychiatric changes</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Progressive cognitive decline in most individuals (unlike most NBIA)</div></li><li class="half_rhythm"><div>Neuropsychiatric changes</div></li><li class="half_rhythm"><div>Spasticity (more prominent than dystonia), motor neuronopathy w/early upper-motor neuron findings followed by signs of lower-motor neuron dysfunction</div></li><li class="half_rhythm"><div>Optic atrophy</div></li><li class="half_rhythm"><div>Slowly progressive course w/survival well into adulthood</div></li></ul></td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/bpan/">BPAN</a></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Childhood</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DD w/slow motor &#x00026; cognitive gains &#x00026; little to no expressive language</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Seizures of various types more prominent in childhood &#x00026; may resolve in later adolescence</div></li><li class="half_rhythm"><div>Abnormal behaviors similar to ASD &#x00026; Rett syndrome</div></li><li class="half_rhythm"><div>Motor dysfunction incl broad-based or ataxic gait, hypotonia, mild spasticity</div></li><li class="half_rhythm"><div>During late adolescence or adulthood, relatively sudden onset of progressive dystonia-parkinsonism &#x00026; dementia</div></li></ul></td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/fahn/">FAHN</a></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Childhood</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Most common presentation is subtle change in gait that may lead to increasingly frequent falls</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Slowly progressive ataxia, dysarthria, dystonia, &#x00026; tetraparesis</div></li><li class="half_rhythm"><div>Optic atrophy leading to progressive loss of visual acuity</div></li><li class="half_rhythm"><div>Seizures in later disease course</div></li><li class="half_rhythm"><div>Progressive intellectual decline in most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals</div></li></ul></td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Kufor-Rakeb syndrome&#x000a0;<sup>3</sup><br />(Parkinson disease 9; PARK9)</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Juvenile</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gait abnormalities, neuropsychiatric changes</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Parkinsonism</div></li><li class="half_rhythm"><div>Dementia</div></li><li class="half_rhythm"><div>Supranuclear gaze palsy</div></li><li class="half_rhythm"><div>Facial-faucial-finger myoclonus</div></li><li class="half_rhythm"><div>Visual hallucinations</div></li><li class="half_rhythm"><div>Oculogyric dystonic spasms&#x000a0;<sup>4</sup></div></li></ul></td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/neuroferritin/">Neuroferritinopathy</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Adult</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">May be similar to <a href="/books/n/gene/huntington/">Huntington disease</a> w/chorea or dystonia &#x00026; cognitive changes</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Progresses from extremity involvement to more generalized movement disorder</div></li><li class="half_rhythm"><div>Characteristic orofacial action-specific dystonia related to speech</div></li></ul></td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/acp/">Aceruloplasminemia</a></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Adult (25-60 yrs)</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical triad of retinal degeneration, diabetes mellitus, &#x00026; neurologic disease</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Facial &#x00026; neck dystonia, dysarthria, tremors, chorea, ataxia, &#x00026; blepharospasm</div></li><li class="half_rhythm"><div>&#x02193; serum concentrations of copper &#x00026; iron &#x00026; &#x02191; serum concentrations of ferritin can distinguish aceruloplasminemia from other forms of NBIA.</div></li></ul></td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/wss/">Woodhouse-Sakati syndrome</a> (hypogonadism, alopecia, diabetes mellitus, ID, &#x00026; extrapyramidal syndrome)&#x000a0;<sup>6</sup></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Childhood</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Alopecia may be earliest symptom; ID &#x00026; delayed puberty</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Progressive extrapyramidal disorder, generalized &#x00026; focal dystonia, dysarthria, &#x00026; cognitive decline</div></li><li class="half_rhythm"><div>Endocrine abnormalities (hypogonadism, alopecia, &#x00026; diabetes mellitus)</div></li></ul></td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">CoPAN&#x000a0;<sup>7</sup></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Childhood</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Childhood-onset dystonia &#x00026; spasticity w/cognitive impairment</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Oromandibular dystonia, dysarthria, axonal neuropathy, parkinsonism, cognitive impairment, &#x00026; obsessive-compulsive behavior</div></li><li class="half_rhythm"><div>Slow progression; non-ambulatory in 3rd decade</div></li></ul></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">ASD = autism spectrm disorder; BPAN = beta-propeller protein-associated neurodegeneration; CoPAN = COASY protein-associated neurodegeneration; DD = developmental delay;ERG = electroretinography; FAHN = fatty acid hydroxylase-associated neurodegeneration; ID = intellectual disability; INAD = infantile neuroaxonal dystrophy; MPAN = mitochondrial membrane protein-associated neurodegeneration; NAD = neuroaxonal dystrophy; PKAN = pantothenate kinase-associated neurodegeneration; PLAN = <i>PLA2G6</i>-associated neurodegeneration</p></div></dd><dt>1. </dt><dd><div id="nbia-ov.TF.3.1"><p class="no_margin">Juvenile PLAN is less common than the infantile form (INAD).</p></div></dd><dt>2. </dt><dd><div id="nbia-ov.TF.3.2"><p class="no_margin">A common C19orf12 <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> (NM_001031726.3: c.204_214del11; NP_001026896.2: p.Gly69ArgfsTer10) has been observed in persons of central European descent (mainly Polish).</p></div></dd><dt>3. </dt><dd><div id="nbia-ov.TF.3.3"><p class="no_margin">Proposed to be an NBIA based on findings described by <a class="bk_pop" href="#nbia-ov.REF.schneider.2010.979">Schneider et al [2010]</a> in a family originally reported in 1994</p></div></dd><dt>4. </dt><dd><div id="nbia-ov.TF.3.4"><p class="no_margin"><a class="bk_pop" href="#nbia-ov.REF.williams.2005.1264">Williams et al [2005]</a></p></div></dd><dt>5. </dt><dd><div id="nbia-ov.TF.3.5"><p class="no_margin">A common <i>FTL</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 4 has been found in approximately 80% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div></dd><dt>6. </dt><dd><div id="nbia-ov.TF.3.6"><p class="no_margin">A founder <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>DCAF17</i> accounts for the cases in the Saudi Arabian population.</p></div></dd><dt>7. </dt><dd><div id="nbia-ov.TF.3.7"><p class="no_margin">The CoPAN <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> will continue to evolve as additional <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are recognized.</p></div></dd></dl></div></div></div><div id="nbia-ov.T.neurodegeneration_with_brain_i_2" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Neurodegeneration with Brain Iron Accumulation: Neuroimaging Findings</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK121988/table/nbia-ov.T.neurodegeneration_with_brain_i_2/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__nbia-ov.T.neurodegeneration_with_brain_i_2_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_1" style="text-align:left;vertical-align:middle;">NBIA Genetic Type</th><th id="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_2" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Brain MRI&#x000a0;<sup>1</sup></th></tr><tr><th headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_2" id="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Pattern of iron distribution</th><th headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_2" id="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Other key radiographic features</th></tr></thead><tbody><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pkan/">PKAN</a></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_2 hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">GP, SN</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_2 hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Eye-of-the-tiger sign&#x000a0;<sup>2</sup> in GP (virtually pathognomonic for PKAN&#x000a0;<sup>3</sup>)</td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/inad/">PLAN</a><br />(Parkinson disease 14; PARK14)</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_2 hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variable GP &#x00026; SN or no iron accumulation</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_2 hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cerebellar atrophy &#x00026; optic atrophy are hallmark features; other features incl cortical cerebellar hyperintensities, white matter abnormalities, thin vertically oriented corpus callosum, apparent hypertrophy of the clavum.</td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mt-mpan/">MPAN</a></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_2 hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">GP, SN</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_2 hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cerebellar &#x00026; cortical atrophy; on T<sub>2</sub>-weighted images hyperintense streaking of medial medullary lamina between globus pallidus interna &#x00026; externa that could be mistaken for eye-of-the-tiger sign</td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/bpan/">BPAN</a></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_2 hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">GP, SN<br />(SN iron &#x0003e; GP iron)</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_2 hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early childhood hypomyelination &#x00026; thin corpus callosum; later development of T<sub>2</sub>-weighted signal hypointensity in SN &#x00026; GP &#x00026; T<sub>1</sub>-weighted signal hyperintensity w/central band of hypointensity in SN. Cerebellar &#x00026; cerebral atrophy may also be present at any age.</td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/fahn/">FAHN</a></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_2 hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">GP, SN</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_2 hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pontocerebellar atrophy, diffuse cerebral atrophy, thinning of corpus callosum, periventricular &#x00026; subcortical white matter hyperintensity on T<sub>2</sub>-weighted images, optic atrophy</td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Kufor-Rakeb syndrome<br />(Parkinson disease 9; PARK9)</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_2 hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variable GP, putamen, caudate, or no iron accumulation&#x000a0;<sup>4</sup></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_2 hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cerebral, cerebellar, &#x00026; brain stem atrophy</td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/neuroferritin/">Neuroferritinopathy</a></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_2 hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">GP, putamen, caudate, dentate, SN &#x00026; RN</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_2 hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cystic changes &#x00026; cavitation in caudate &#x00026; putamen (unique to neuroferritinopathy); mild cortical &#x00026; cerebellar atrophy</td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/acp/">Aceruloplasminemia</a></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_2 hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">GP, putamen, caudate, thalamus, RN, dentate&#x000a0;<sup>5</sup></td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_2 hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cerebellar atrophy</td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/wss/">Woodhouse-Sakati syndrome</a> (hypogonadism, alopecia, diabetes mellitus, ID, &#x00026; extrapyramidal syndrome)</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_2 hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">GP</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_2 hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">White matter disease is common.</td></tr><tr><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CoPAN</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_2 hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">GP, SN</td><td headers="hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_1_2 hd_h_nbia-ov.T.neurodegeneration_with_brain_i_2_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">T<sub>2</sub>-weighted images: hyperintense caudate, putamina, medial &#x00026; posterior thalami in early disease,&#x000a0;<sup>6</sup> GP calcifications</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">BPAN = beta-propeller protein-associated neurodegeneration; CoPAN = COASY protein-associated neurodegeneration; FAHN = fatty acid hydroxylase-associated neurodegeneration; GP = globus pallidus; ID = intellectual disability; MPAN = mitochondrial membrane protein-associated neurodegeneration; PKAN = pantothenate kinase-associated neurodegeneration; PLAN = <i>PLA2G6</i>-associated neurodegeneration; RN = red nucleus; SN = substantia nigra</p></div></dd><dt>1. </dt><dd><div id="nbia-ov.TF.4.1"><p class="no_margin">For a more comprehensive overview of the radiographic findings in NBIA, see <a class="bk_pop" href="#nbia-ov.REF.kruer.2012.407">Kruer et al [2012]</a>.</p></div></dd><dt>2. </dt><dd><div id="nbia-ov.TF.4.2"><p class="no_margin">Eye-of-the-tiger sign = T<sub>2</sub>-weighted hypointense signal in the globus pallidus with a central region of hyperintensity</p></div></dd><dt>3. </dt><dd><div id="nbia-ov.TF.4.3"><p class="no_margin"><a class="bk_pop" href="#nbia-ov.REF.hayflick.2003.33">Hayflick et al [2003]</a></p></div></dd><dt>4. </dt><dd><div id="nbia-ov.TF.4.4"><p class="no_margin">Similar to PLAN, it has been suggested that some individuals may not have iron accumulation, it may develop late in the disease course, or it may only be associated with more severe pathogenic variants [<a class="bk_pop" href="#nbia-ov.REF.chien.2011.1364">Chien et al 2011</a>].</p></div></dd><dt>5. </dt><dd><div id="nbia-ov.TF.4.5"><p class="no_margin">Abnormal hypointensities in liver are common (liver iron content &#x0003e; basal ganglia iron content).</p></div></dd><dt>6. </dt><dd><div id="nbia-ov.TF.4.6"><p class="no_margin">In one individual early in disease, T<sub>2</sub>-weighted sequences showed hyperintense &#x00026; swollen caudate nuclei &#x00026; putamina &#x00026; mild hyperintensity in the medial &#x00026; posterior thalami, which may help distinguish CoPAN from other NBIA disorders if these features are observed in additional cases.</p></div></dd></dl></div></div></div><p><b>NBIA of unknown cause.</b> A significant portion of individuals with clinical, radiographic, and sometimes neuropathologic evidence of NBIA do not have pathogenic variants identified in one of the ten known NBIA-related genes [<a class="bk_pop" href="#nbia-ov.REF.hogarth.2013.268">Hogarth et al 2013</a>] (see <a class="figpopup" href="/books/NBK121988/figure/nbia-ov.F1/?report=objectonly" target="object" rid-figpopup="fignbiaovF1" rid-ob="figobnbiaovF1">Figure 1</a>). For the most part, these individuals do not stratify into clear phenotypic groups.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="fignbiaovF1" co-legend-rid="figlgndnbiaovF1"><a href="/books/NBK121988/figure/nbia-ov.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="fignbiaovF1" rid-ob="figobnbiaovF1"><img class="small-thumb" src="/books/NBK121988/bin/nbia-ov-Image001.gif" src-large="/books/NBK121988/bin/nbia-ov-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndnbiaovF1"><h4 id="nbia-ov.F1"><a href="/books/NBK121988/figure/nbia-ov.F1/?report=objectonly" target="object" rid-ob="figobnbiaovF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">NBIA Types PKAN = pantothenate kinase-associated neurodegeneration</p></div></div></div><div id="nbia-ov._escape__3_Evaluation_Strategies"><h2 id="_nbia-ov__escape__3_Evaluation_Strategies_">3. Evaluation Strategies to Identify the Genetic Cause of Neurodegeneration with Brain Iron Accumulation in a Proband</h2><p>Establishing a specific genetic cause of NBIA:</p><ul><li class="half_rhythm"><div>Can aid in discussions of prognosis (which are beyond the scope of this <i>GeneReview</i>), <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a>, and treatment options;</div></li><li class="half_rhythm"><div>Usually involves a medical history, physical examination, laboratory testing, family history, and <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a>/genetic testing.</div></li></ul><p><b>Medical history.</b> See <a class="figpopup" href="/books/NBK121988/table/nbia-ov.T.neurodegeneration_with_brain_i_1/?report=objectonly" target="object" rid-figpopup="fignbiaovTneurodegenerationwithbraini1" rid-ob="figobnbiaovTneurodegenerationwithbraini1">Table 3</a> for clinical characteristics and <a class="figpopup" href="/books/NBK121988/table/nbia-ov.T.neurodegeneration_with_brain_i_2/?report=objectonly" target="object" rid-figpopup="fignbiaovTneurodegenerationwithbraini2" rid-ob="figobnbiaovTneurodegenerationwithbraini2">Table 4</a> for neuroimaging findings that could lead a clinician to suspect or consider a specific genetic type of NBIA (<a class="figpopup" href="/books/NBK121988/table/nbia-ov.T.neurodegeneration_with_brain_i/?report=objectonly" target="object" rid-figpopup="fignbiaovTneurodegenerationwithbraini" rid-ob="figobnbiaovTneurodegenerationwithbraini">Table 2</a>).</p><p><b>Physical examination.</b> See <a class="figpopup" href="/books/NBK121988/table/nbia-ov.T.neurodegeneration_with_brain_i_1/?report=objectonly" target="object" rid-figpopup="fignbiaovTneurodegenerationwithbraini1" rid-ob="figobnbiaovTneurodegenerationwithbraini1">Table 3</a> for clinical characteristics that could help the clinician identify key issues in the physical examination that would allow him/her to suspect and/or consider a specific genetic type of NBIA (<a class="figpopup" href="/books/NBK121988/table/nbia-ov.T.neurodegeneration_with_brain_i/?report=objectonly" target="object" rid-figpopup="fignbiaovTneurodegenerationwithbraini" rid-ob="figobnbiaovTneurodegenerationwithbraini">Table 2</a>).</p><p><b>Family history.</b> A three-generation family history should be taken, with attention to relatives with manifestations of NBIA and documentation of relevant findings through direct examination or review of medical records, including results of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p><p><b>Molecular genetic testing</b> approaches can include a combination of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing (single-gene testing or <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> (<a href="#nbia-ov.Option_1">Option 1</a>) and comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>) (<a href="#nbia-ov.Option_2">Option 2</a>). Gene-targeted testing requires the clinician to hypothesize which gene(s) are likely involved, whereas genomic testing does not.</p><div id="nbia-ov.Option_1"><h3>Option 1</h3><p><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of one gene, followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>) is useful when the neuroimaging and/or <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> clearly point toward one NBIA-related gene. For example, an eye-of-the-tiger sign on brain MRI is nearly pathognomonic for PKAN caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>PANK2</i> pathogenic variants.</p><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes some or all of the genes listed in <a class="figpopup" href="/books/NBK121988/table/nbia-ov.T._escape_conditions_with_brain/?report=objectonly" target="object" rid-figpopup="fignbiaovTescapeconditionswithbrain" rid-ob="figobnbiaovTescapeconditionswithbrain">Table 1</a> is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. Of note, given the rarity of some of the genes associated with NBIA, some panels may not include all the genes mentioned in this overview. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p></div><div id="nbia-ov.Option_2"><h3>Option 2</h3><p><b>Comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) may be considered when clinical/neuroimaging findings have not suggested NBIA. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>If <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic, <b><a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a></b> (when clinically available) may be considered to detect (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><p><b>Note:</b> For individuals in whom a genetic cause of NBIA cannot be established, participation in research studies may be considered as new technologies may facilitate identification of additional NBIA-related genes in the future (see <a href="#nbia-ov._escape__5_Management_of_Neurode">Resources</a>).</p></div></div><div id="nbia-ov._escape__4_Genetic_Counseling_of"><h2 id="_nbia-ov__escape__4_Genetic_Counseling_of_">4. Genetic Counseling of Family Members of an Individual with Neurodegeneration with Brain Iron Accumulation</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="nbia-ov.Modes_of_Inheritance"><h3>Modes of Inheritance</h3><p>Seven of the ten genetically defined types of neurodegeneration with brain iron accumulation (NBIA) are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. Exceptions:</p><ul><li class="half_rhythm"><div>Neuroferritinopathy, an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> disorder caused by a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FTL</i></div></li><li class="half_rhythm"><div>Mitochondrial membrane protein-associated neurodegeneration (MPAN), an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> disorder caused by mutation of <i>C19orf12</i> (<a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> and inherited pathogenic variants are known to be associated with autosomal dominant MPAN)</div></li><li class="half_rhythm"><div>Beta-propeller protein-associated neurodegeneration (BPAN), an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> or inherited <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>WDR45</i> with suspected male lethality (To date, most individuals with BPAN have been female.)</div></li></ul></div><div id="nbia-ov.Autosomal_Recessive_Inheritance"><h3>Autosomal Recessive Inheritance</h3><div id="nbia-ov.Risk_to_Family_Members"><h4>Risk to Family Members</h4><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (i.e., carriers of one NBIA-causing <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Individuals with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> forms of NBIA rarely reproduce due to the severity of the condition.</div></li><li class="half_rhythm"><div>Those with later-onset, atypical disease may have offspring; all offspring will be obligate heterozygotes.</div></li></ul><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an NBIA-causing <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="nbia-ov.Carrier_Heterozygote_Detection"><h4>Carrier (Heterozygote) Detection</h4><p>Carrier testing for at-risk family members requires prior identification of the pathogenic variants in the family.</p></div></div><div id="nbia-ov.XLinked_Inheritance__Risk_to_Fam"><h3>X-Linked Inheritance &#x02013; Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>To date, the vast majority of reported individuals with BPAN have been <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) and have had a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>WDR45</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Rarely, an individual with BPAN has the disorder as the result of an inherited <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. In one family, an asymptomatic mother had the same <i>WDR45</i> pathogenic variant as her sons with significant <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> skewed toward the normal <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> in her leukocyte DNA [<a class="bk_pop" href="#nbia-ov.REF.dufke.2014">Dufke et al 2014</a>].</div></li><li class="half_rhythm"><div>Recommended parental <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> when a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has an identified <i>WDR45</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>:</div><ul><li class="half_rhythm"><div><b>Female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Molecular genetic testing of both parents</div></li><li class="half_rhythm"><div><b>Male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Molecular genetic testing of the mother only; the father of a male proband will neither have the disorder nor be <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> for the <i>WDR45</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li></ul></li><li class="half_rhythm"><div>In a family with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, the mother of an affected male is an <a class="def" href="/books/n/gene/glossary/def-item/obligate-heterozygote/">obligate heterozygote</a>. Note: If a woman has more than one affected child and no other affected relatives and if the <i>WDR45</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in her leukocyte DNA, she most likely has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>. Presumed maternal germline mosaicism has been reported in a family with two affected sibs [<a class="bk_pop" href="#nbia-ov.REF.zarate.2016.1080">Zarate et al 2016</a>].</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> To date, nearly all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have had a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>WDR45</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, suggesting a low risk to sibs.</p><ul><li class="half_rhythm"><div>The risk to sibs of a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the parents. The risk to sibs of a male proband depends on the genetic status of the mother.</div></li><li class="half_rhythm"><div>If a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) and if the <i>WDR45</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the mother or father's leukocyte DNA (female proband) or in the mother's leukocyte DNA (male proband), the risk to sibs is greater than that of the general population because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#nbia-ov.REF.zarate.2016.1080">Zarate et al 2016</a>].</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div><b>Female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Females with the typical BPAN <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> do not reproduce. In rare cases, a mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> female with somatic/<a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#nbia-ov.REF.haack.2012.1144">Haack et al 2012</a>, <a class="bk_pop" href="#nbia-ov.REF.zarate.2016.1080">Zarate et al 2016</a>] or skewed <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> [<a class="bk_pop" href="#nbia-ov.REF.dufke.2014">Dufke et al 2014</a>] may reproduce (see <a href="/books/n/gene/bpan/#bpan.Genetic_Counseling">BPAN, Genetic Counseling</a> for more detailed information).</div></li><li class="half_rhythm"><div><b>Male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Affected males do not reproduce.</div></li></ul><p><b>Other family members.</b> Given that most probands with BPAN reported to date have the disorder as a result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>WDR45</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to other family members is presumed to be low.</p></div><div id="nbia-ov.Autosomal_Dominant_Inheritance"><h3>Autosomal Dominant Inheritance &#x02013; Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div><b>Neuroferritinopathy.</b> Most individuals diagnosed with neuroferritinopathy have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. More rarely, a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (the proportion of <i>de novo</i> cases in neuroferritinopathy is unknown).</div></li><li class="half_rhythm"><div><b>Autosomal dominant MPAN.</b> Rarely, individuals diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> MPAN have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. More often, a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with autosomal dominant MPAN has the disorder as a result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 3 of <i>C19orf12</i> that leads to a protein truncated after amino acid 79 [<a class="bk_pop" href="#nbia-ov.REF.gregory.2019.e00736">Gregory et al 2019</a>].</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FTL</i> include brain MRI, measurement of serum ferritin concentration, and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for the pathogenic variant identified in the proband.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to the sibs of inheriting the NBIA-causing <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is 50%.</div><ul><li class="half_rhythm"><div>Penetrance of neuroferritinopathy is 100%; however, there may be differences in the age of onset and rate of progression in <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> sibs.</div></li><li class="half_rhythm"><div>Reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is suggested in two individuals in the two families with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> MPAN reported to date [<a class="bk_pop" href="#nbia-ov.REF.gregory.2019.e00736">Gregory et al 2019</a>].</div></li></ul></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a known <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that cannot be detected in the leukocyte DNA of either parent, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is estimated to be 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#nbia-ov.REF.rahbari.2016.126">Rahbari et al 2016</a>].</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with neuroferritinopathy or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> MPAN has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. There may be differences in the age of onset and rate of progression of the disorder between members of the same family.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or has the NBIA-causing <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members are at risk.</p><p><b>Predictive testing of at-risk asymptomatic adult family members</b> requires prior identification of the NBIA-causing <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family. See <a href="/books/n/gene/neuroferritin/#neuroferritin.Genetic_Counseling">Neuroferritinopathy, Genetic Counseling</a> for a review of issues related to predictive testing.</p></div><div id="nbia-ov.Related_Genetic_Counseling_Issue"><h3>Related Genetic Counseling Issues</h3><p><b>Family</b>
<b>planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a>, or are at risk of being heterozygous.</div></li></ul></div><div id="nbia-ov.Prenatal_Testing_and_Preimplanta"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the NBIA-causing <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="nbia-ov.Resources"><h2 id="_nbia-ov_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>INADcure Foundation</b></div><div><b>Email:</b> info@INADcure.org</div><div><a href="https://inadcure.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.INADcure.org</a></div></li><li class="half_rhythm"><div><b>NBIA Alliance</b></div><div><b>Email:</b> Info@NBIAalliance.org</div><div><a href="http://www.nbiaalliance.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nbiaalliance.org</a></div></li><li class="half_rhythm"><div><b>NBIAcure</b></div><div>Center of Excellence for NBIA Clinical Care and Research</div><div>International Registry for NBIA and Related Disorders</div><div>Oregon Health &#x00026; Science University</div><div><b>Phone:</b> 503-494-4344</div><div><b>Fax:</b> 503-494-6886</div><div><b>Email:</b> gregorya@ohsu.edu</div><div><a href="http://nbiacure.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nbiacure.org</a></div></li><li class="half_rhythm"><div><b>NBIA Disorders Association</b></div><div>2082 Monaco Court</div><div>El Cajon CA 92019-4235</div><div><b>Phone:</b> 619-588-2315</div><div><b>Fax:</b> 619-588-4093</div><div><b>Email:</b> info@NBIAdisorders.org</div><div><a href="https://www.nbiadisorders.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nbiadisorders.org</a></div></li><li class="half_rhythm"><div><b>NBIA Disorders Association Research Registry and Treat Iron-Related Childhood-Onset Neurodegeneration (TIRCON) Registry</b></div><div> CA 92019-4235</div><div><b>Phone:</b> 619-588-2315</div><div><b>Fax:</b> 619-588-4093</div><div><b>Email:</b> pwood@nbiadisorders.org</div><div><a href="http://www.nbiadisorders.org/research/patient-registry?highlight=YToxOntpOjA7czo4OiJyZWdpc3RyeSI7fQ==" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">International Patient Registry &#x00026; Biomaterial Bank</a></div></li><li class="half_rhythm"><div><b>Treat Iron-Related Childhood Onset Neurodegeneration (TIRCON) Registry</b></div><div>Germany</div><div><b>Phone:</b> 49-89-5160-7421</div><div><b>Fax:</b> 49-89-5160-7402</div><div><b>Email:</b> tircon@med.uni-muenchen.de</div><div><a href="http://tircon.eu/tircon-workpackages/wp1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://tircon.eu/tircon-workpackages/wp1</a></div></li></ul></div><div id="nbia-ov._escape__5_Management_of_Neurode"><h2 id="_nbia-ov__escape__5_Management_of_Neurode_">5. Management of Neurodegeneration with Brain Iron Accumulation</h2><div id="nbia-ov.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Treatments for NBIA disorders are palliative and should be tailored to the specific NBIA disorder and to the individual patient. A consensus management guideline for PKAN has been published [<a class="bk_pop" href="#nbia-ov.REF.hogarth.2017.278">Hogarth et al 2017</a>]. The following treatments should be considered (some do not apply to all genetic types of NBIA):</p><ul><li class="half_rhythm"><div>Pharmacologic treatment of spasticity and seizures</div></li><li class="half_rhythm"><div>Trial of oral or intrathecal baclofen for those with significant dystonia</div></li><li class="half_rhythm"><div>Botulinum toxin for those with focal dystonia</div></li><li class="half_rhythm"><div>L-DOPA treatment, which is beneficial in rare cases. Note: Some will have an initially dramatic response that usually diminishes over time; some will develop prominent dyskinesias early in the treatment.</div></li><li class="half_rhythm"><div>Deep brain stimulation, used clinically for dystonia with increasing frequency, shows some evidence of benefit.</div></li><li class="half_rhythm"><div>Psychiatric treatment for those with a later-onset, more protracted course accompanied by neuropsychiatric symptoms</div></li></ul><p>As NBIA disorders progress, many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may experience episodes of extreme dystonia lasting for days or weeks. It is especially important during these episodes to evaluate for treatable causes of pain, which may include occult GI bleeding, urinary tract infections, and occult bone fractures. The combination of osteopenia in a non-ambulatory person with marked stress on the long bones from dystonia places many individuals with an NBIA disorder at high risk for fractures without apparent trauma.</p><p>Patients benefit from services for the blind, educational programs, and assistive communication devices; adaptive aids (walkers, wheelchairs) may be required for gait abnormalities.</p><p>Swallowing evaluation and regular dietary assessments are indicated to assure adequate nutrition. Once the individual can no longer maintain an adequate diet orally, gastrostomy tube placement is indicated.</p><p>Gastric feeding tube and/or tracheostomy is appropriate as needed to prevent aspiration pneumonia.</p><p>Over-the-counter fiber supplements and/or stool softeners are indicated to treat constipation, which is likely caused by a combination of immobility, diet, and medications.</p></div><div id="nbia-ov.Surveillance"><h3>Surveillance</h3><p>Evaluate for treatable causes of pain during episodes of extreme dystonia. The following should be performed on a regular basis:</p><ul><li class="half_rhythm"><div>Monitoring of height and weight using appropriate growth curves to screen children for worsening nutritional status</div></li><li class="half_rhythm"><div>Ophthalmologic assessment</div></li><li class="half_rhythm"><div>Assessment of ambulation and speech abilities</div></li></ul></div></div><div id="nbia-ov.References"><h2 id="_nbia-ov_References_">References</h2><div id="nbia-ov.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="nbia-ov.REF.alsemari.2007.149">Al-Semari A, Bohlega S. Autosomal-recessive syndrome with alopecia, hypogonadism, progressive extra-pyramidal disorder, white matter disease, sensory neural deafness, diabetes mellitus, and low IGF1. <span><span class="ref-journal">Am J Med Genet A. </span>2007;<span class="ref-vol">143A</span>:149–60.</span> [<a href="/pubmed/17167799" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17167799</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nbia-ov.REF.behrens.2010.1929">Behrens MI, Br&#x000fc;ggemann N, Chana P, Venegas P, K&#x000e4;gi M, Parrao T, Orellana P, Garrido C, Rojas CV, Hauke J, Hahnen E, Gonz&#x000e1;lez R, Seleme N, Fern&#x000e1;ndez V, Schmidt A, Binkofski F, K&#x000f6;mpf D, Kubisch C, Hagenah J, Klein C, Ramirez A. Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations. <span><span class="ref-journal">Mov Disord. </span>2010;<span class="ref-vol">25</span>:1929–37.</span> [<a href="/pubmed/20683840" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20683840</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nbia-ov.REF.br_ggemann.2010.1357">Br&#x000fc;ggemann N, Hagenah J, Reetz K, Schmidt A, Kasten M, Buchmann I, Eckerle S, B&#x000e4;hre M, M&#x000fc;nchau A, Djarmati A, van der Vegt J, Siebner H, Binkofski F, Ramirez A, Behrens MI, Klein C. Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype. <span><span class="ref-journal">Arch Neurol. </span>2010;<span class="ref-vol">67</span>:1357–63.</span> [<a href="/pubmed/21060012" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21060012</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nbia-ov.REF.chien.2011.1364">Chien HF, Bonifati V, Barbosa ER. ATP13A2-related neurodegeneration (PARK9) without evidence of brain iron accumulation. <span><span class="ref-journal">Mov Disord. </span>2011;<span class="ref-vol">26</span>:1364–5.</span> [<a href="/pubmed/21469196" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21469196</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nbia-ov.REF.dick.2008.248">Dick KJ, Al-Mjeni R, Baskir W, Koul R, Simpson MA, Patton MA, Raeburn S, Crosby AH. A novel locus for an autosomal recessive hereditary spastic paraplegia (SPG35) maps to 16q21-q23. <span><span class="ref-journal">Neurology. </span>2008;<span class="ref-vol">71</span>:248–52.</span> [<a href="/pubmed/18463364" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18463364</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nbia-ov.REF.dick.2010.e1251">Dick KJ, Eckhardt M, Pais&#x000e1;n-Ruiz C, Alshehhi AA, Proukakis C, Sibtain NA, Maier H, Sharifi R, Patton MA, Bashir W, Koul R, Raeburn S, Gieselmann V, Houlden H, Crosby AH. Mutation of FA2H underlies a complicated form of hereditary spastic paraplegia (SPG35). <span><span class="ref-journal">Hum Mutat. </span>2010;<span class="ref-vol">31</span>:E1251–60.</span> [<a href="/pubmed/20104589" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20104589</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nbia-ov.REF.dufke.2014">Dufke A, Grasshoff U, Dufke C, Kalscheuer V, Schroeder C, Beck-Wodl S, Tzschach A, Nagele T, Riess O, Bauer P, Krageloh-Mann I. NGS based whole X-exome analysis reveals a familial WDR45 missense mutation in 3 males with intellectual disability and brain iron accumulation. Abstract P08.53-S. Milan, Italy: European Society of Human Genetics Conference. 2014.</div></li><li class="half_rhythm"><div class="bk_ref" id="nbia-ov.REF.dusi.2014.11">Dusi S, Valletta L, Haack TB, Tsuchiya Y, Venco P, Pasqualato S, Goffrini P, Tigano M, Demchenko N, Wieland T, Schwarzmayr T, Strom TM, Invernizzi F, Garavaglia B, Gregory A, Sanford L, Hamada J, Bettencourt C, Houlden H, Chiapparini L, Zorzi G, Kurian MA, Nardocci N, Prokisch H, Hayflick S, Gout I, Tiranti V. Exome sequence reveals mutations in CoA synthase as a cause of neurodegeneration with brain iron accumulation. <span><span class="ref-journal">Am J Hum Genet. </span>2014;<span class="ref-vol">94</span>:11–22.</span> [<a href="/pmc/articles/PMC3882905/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3882905</span></a>] [<a href="/pubmed/24360804" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24360804</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nbia-ov.REF.edvardson.2008.643">Edvardson S, Hama H, Shaag A, Gomori JM, Berger I, Soffer D, Korman SH, Taustein I, Saada A, Elpeleg O. Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia. <span><span class="ref-journal">Am J Hum Genet. </span>2008;<span class="ref-vol">83</span>:643–8.</span> [<a href="/pmc/articles/PMC2668027/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2668027</span></a>] [<a href="/pubmed/19068277" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19068277</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nbia-ov.REF.eiberg.2012.256">Eiberg H, Hansen L, Korbo L, Nielsen IM, Svenstrup K, Bech S, Pinborg LH, Friberg L, Hjermind LE, Olsen OR, Nielsen JE. Novel mutation in ATP13A2 widens the spectrum of Kufor-Rakeb syndrome (PARK9). <span><span class="ref-journal">Clin Genet. </span>2012;<span class="ref-vol">82</span>:256–63.</span> [<a href="/pubmed/21696388" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21696388</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nbia-ov.REF.evers.2017.1878">Evers C, Seitz A, Assmann B, Opladen T, Karch S, Hinderhofer K, Granzow M, Paramasivam N, Eils R, Diessl N, Bartram CR, Moog U. Diagnosis of CoPAN by whole exome sequencing: waking up a sleeping tiger&#x02019;s eye. <span><span class="ref-journal">Am J Med Genet. </span>2017;<span class="ref-vol">173</span>:1878–86.</span> [<a href="/pubmed/28489334" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28489334</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nbia-ov.REF.gregory.2019.e00736">Gregory A, Lotia M, Jeong SY, Fox R, Zhen D, Sanford L, Hamada J, Jahic A, Beetz C, Freed A, Kurian MA, Cullup T, van der Weijden MCM, Nguyen V, Setthavongsack N, Garcia D, Krajbich V, Pham T, Woltjer R, George BP, Minks KQ, Paciorkowski AR, Hogarth P, Jankovic J, Hayflick SJ. Autosomal dominant mitochondrial membrane protein-associated neurodegeneration (MPAN). <span><span class="ref-journal">Mol Genet Genomic Med. </span>2019;<span class="ref-vol">7</span>:e00736.</span> [<a href="/pmc/articles/PMC6625130/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6625130</span></a>] [<a href="/pubmed/31087512" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 31087512</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nbia-ov.REF.haack.2012.1144">Haack TB, Hogarth P, Kruer MC, Gregory A, Wieland T, Schwarzmayr T, Graf E, Sanford L, Meyer E, Kara E, Cuno SM, Harik SI, Dandu VH, Nardocci N, Zorzi G, Dunaway T, Tarnopolsky M, Skinner S, Frucht S, Hanspal E, Schrander-Stumpel C, H&#x000e9;ron D, Mignot C, Garavaglia B, Bhatia K, Hardy J, Strom TM, Boddaert N, Houlden HH, Kurian MA, Meitinger T, Prokisch H, Hayflick SJ. Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">91</span>:1144–9.</span> [<a href="/pmc/articles/PMC3516593/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3516593</span></a>] [<a href="/pubmed/23176820" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23176820</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nbia-ov.REF.hayflick.2003.33">Hayflick SJ, Westaway SK, Levinson B, Zhou B, Johnson MA, Ching KH, Gitschier J. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. <span><span class="ref-journal">N Engl J Med. </span>2003;<span class="ref-vol">348</span>:33–40.</span> [<a href="/pubmed/12510040" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12510040</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nbia-ov.REF.hogarth.2013.268">Hogarth P, Gregory A, Kruer MC, Sanford L, Wagoner W, Natowicz MR, Egel RT, Subramony SH, Goldman JG, Berry-Kravis E, Foulds NC, Hammans SR, Desguerre I, Rodriguez D, Wilson C, Diedrich A, Green S, Tran H, Reese L, Woltjer RL, Hayflick SJ. New NBIA subtype: Genetic, clinical, pathologic, and radiographic features of MPAN. <span><span class="ref-journal">Neurology. </span>2013;<span class="ref-vol">80</span>:268–75.</span> [<a href="/pmc/articles/PMC3589182/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3589182</span></a>] [<a href="/pubmed/23269600" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23269600</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nbia-ov.REF.hogarth.2017.278">Hogarth P, Kurian MA, Gregory A, Csanyi B, Zagustin T, Kmiec T, Wood P, Klucken A, Scalise N, Sofia F, Klopstock T, Zorzi G, Nardocci N, Hayflick SJ. Consensus clinical management guildeline for pantothenate kinase-associated neurodegeneration (PKAN). <span><span class="ref-journal">Mol Genet Metab. </span>2017;<span class="ref-vol">120</span>(3):278–87.</span> [<a href="/pubmed/28034613" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28034613</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nbia-ov.REF.kruer.2012.407">Kruer MC, Boddaert N, Schneider SA, Houlden H, Bhatia KP, Gregory A, Anderson JC, Rooney WD, Hogarth P, Hayflick SJ. Neuroimaging features of neurodegeneration with brain iron accumulation. <span><span class="ref-journal">AJNR Am J Neuroradiol. </span>2012;<span class="ref-vol">33</span>:407–14.</span> [<a href="/pubmed/21920862" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21920862</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nbia-ov.REF.kruer.2010.611">Kruer MC, Pais&#x000e1;n-Ruiz C, Boddaert N, Yoon MY, Hama H, Gregory A, Malandrini A, Woltjer RL, Munnich A, Gobin S, Polster BJ, Palmeri S, Edvardson S, Hardy J, Houlden H, Hayflick SJ. Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA). <span><span class="ref-journal">Ann Neurol. </span>2010;<span class="ref-vol">68</span>:611–8.</span> [<a href="/pmc/articles/PMC6059612/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6059612</span></a>] [<a href="/pubmed/20853438" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20853438</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nbia-ov.REF.rahbari.2016.126">Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Turki SA, Dominiczak A, Morris A, Porteous D, Smith B, Stratton MR, Hurles ME, et al.  Timing, rates and spectra of human germline mutation. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:126–33.</span> [<a href="/pmc/articles/PMC4731925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4731925</span></a>] [<a href="/pubmed/26656846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26656846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nbia-ov.REF.schneider.2010.979">Schneider SA, Pais&#x000e1;n-Ruiz C, Quinn NP, Lees AJ, Houlden H, Hardy J, Bhatia KP. ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation. <span><span class="ref-journal">Mov Disord. </span>2010;<span class="ref-vol">25</span>:979–84.</span> [<a href="/pubmed/20310007" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20310007</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nbia-ov.REF.williams.2005.1264">Williams DR, Hadeed A, al-Din AS, Wreikat AL, Lees AJ. Kufor Rakeb disease: autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia. <span><span class="ref-journal">Mov Disord. </span>2005;<span class="ref-vol">20</span>:1264–71.</span> [<a href="/pubmed/15986421" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15986421</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nbia-ov.REF.woodhouse.1983.216">Woodhouse NJ, Sakati NA. A syndrome of hypogonadism, alopecia, diabetes mellitus, mental retardation, deafness, and ECG abnormalities. <span><span class="ref-journal">J Med Genet. </span>1983;<span class="ref-vol">20</span>:216–9.</span> [<a href="/pmc/articles/PMC1049050/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1049050</span></a>] [<a href="/pubmed/6876115" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6876115</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="nbia-ov.REF.zarate.2016.1080">Zarate YA, Jones JR, Jones MA, Millan F, Juusola J, Vertino-Bell A, Schaefer GB, Kruer MC. Lessons from a pair of siblings with BPAN. <span><span class="ref-journal">Eur J Hum Genet. </span>2016;<span class="ref-vol">24</span>:1080–3.</span> [<a href="/pmc/articles/PMC5070893/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5070893</span></a>] [<a href="/pubmed/26577041" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26577041</span></a>]</div></li></ul></div></div><div id="nbia-ov.Chapter_Notes"><h2 id="_nbia-ov_Chapter_Notes_">Chapter Notes</h2><div id="nbia-ov.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>21 October 2019 (bp) Comprehensive update posted live</div></li><li class="half_rhythm"><div>24 April 2014 (aa) Revision: COASY protein-associated neurodegeneration added</div></li><li class="half_rhythm"><div>28 February 2013 (me) Review posted live</div></li><li class="half_rhythm"><div>23 April 2012 (ag) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK121988</span><span class="label">PMID: <a href="/pubmed/23447832" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">23447832</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/nephron-ov/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/neuroferritin/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK121988&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK121988/?report=reader">PubReader</a></li><li><a href="/books/NBK121988/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK121988" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK121988" style="display:none" title="Cite this Page"><div class="bk_tt">Gregory A, Hayflick S. Neurodegeneration with Brain Iron Accumulation Disorders Overview. 2013 Feb 28 [Updated 2019 Oct 21]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK121988/pdf/Bookshelf_NBK121988.pdf">PDF version of this page</a> (460K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#nbia-ov.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#nbia-ov._escape__1_Clinical_Characterist" ref="log$=inpage&amp;link_id=inpage">1. Clinical Characteristics of Neurodegeneration with Brain Iron Accumulation</a></li><li><a href="#nbia-ov._escape__2_Genetic_Causes_of_Neu" ref="log$=inpage&amp;link_id=inpage">2. Genetic Causes of Neurodegeneration with Brain Iron Accumulation</a></li><li><a href="#nbia-ov._escape__3_Evaluation_Strategies" ref="log$=inpage&amp;link_id=inpage">3. Evaluation Strategies to Identify the Genetic Cause of Neurodegeneration with Brain Iron Accumulation in a Proband</a></li><li><a href="#nbia-ov._escape__4_Genetic_Counseling_of" ref="log$=inpage&amp;link_id=inpage">4. Genetic Counseling of Family Members of an Individual with Neurodegeneration with Brain Iron Accumulation</a></li><li><a href="#nbia-ov.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#nbia-ov._escape__5_Management_of_Neurode" ref="log$=inpage&amp;link_id=inpage">5. Management of Neurodegeneration with Brain Iron Accumulation</a></li><li><a href="#nbia-ov.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#nbia-ov.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=80025[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PANK2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2512[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FTL</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=79152[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FA2H</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1356[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CP</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=55229[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PANK4</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=80347[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COASY</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=83636[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">C19orf12</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=80067[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">DCAF17</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=8398[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PLA2G6</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=11152[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">WDR45</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=23400[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ATP13A2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=3012684" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=3012684" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301334" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hereditary Dystonia Overview</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hereditary Dystonia Overview<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Klein C, Lohmann K, Marras C, Münchau A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29325618" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Neurodegeneration with brain iron accumulation.</a><span class="source">[Handb Clin Neurol. 2018]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Neurodegeneration with brain iron accumulation.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Hayflick SJ, Kurian MA, Hogarth P. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Handb Clin Neurol. 2018; 147:293-305. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25870938" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Review: Insights into molecular mechanisms of disease in neurodegeneration with brain iron accumulation: unifying theories.</a><span class="source">[Neuropathol Appl Neurobiol. 2016]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Review: Insights into molecular mechanisms of disease in neurodegeneration with brain iron accumulation: unifying theories.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Arber CE, Li A, Houlden H, Wray S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Neuropathol Appl Neurobiol. 2016 Apr; 42(3):220-41. Epub 2015 Jun 2.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31404774" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Neurodegeneration with brain iron accumulation: Insights into the mitochondria dysregulation.</a><span class="source">[Biomed Pharmacother. 2019]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Neurodegeneration with brain iron accumulation: Insights into the mitochondria dysregulation.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wang ZB, Liu JY, Xu XJ, Mao XY, Zhang W, Zhou HH, Liu ZQ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Biomed Pharmacother. 2019 Oct; 118:109068. Epub 2019 Aug 9.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27487380" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> A diagnostic approach for neurodegeneration with brain iron accumulation: clinical features, genetics and brain imaging.</a><span class="source">[Arq Neuropsiquiatr. 2016]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> A diagnostic approach for neurodegeneration with brain iron accumulation: clinical features, genetics and brain imaging.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Salomão RP, Pedroso JL, Gama MT, Dutra LA, Maciel RH, Godeiro-Junior C, Chien HF, Teive HA, Cardoso F, Barsottini OG. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Arq Neuropsiquiatr. 2016 Jul; 74(7):587-96. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=23447832" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=23447832" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0412c7dd21425a25ba2fcf">Neurodegeneration with Brain Iron Accumulation Disorders Overview - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Neurodegeneration with Brain Iron Accumulation Disorders Overview - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:54:15-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8AC2A1E040BF310000000002DA0104&amp;ncbi_session=CE8AC2A1E0412C61_0730SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK121988%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK121988&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK121988/&amp;ncbi_pagename=Neurodegeneration with Brain Iron Accumulation Disorders Overview - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8AC2A1E0412C61_0730SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>